acetazolamide
- Product NDC
- 42291-090
- 11-digit product format
- 422910090
- Labeler code
- 42291
- Product ID
- 42291-090_4b947afe-c73a-556b-e063-6294a90adeef
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acetazolamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA205530
- Marketing category
- ANDA
- Marketing start
- 2017-05-18
- Substance
- ACETAZOLAMIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- acetazolamide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACETAZOLAMIDE | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O3FX965V0I |
| Rxcui | 197303, 197304 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42291-090-01 | acetazolamide | 100 in 1 BOTTLE | TABLET | 100 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-090 | ACETAZOLAMIDE TABLET [AVKARE] | 5 | Current NDC, Legacy NDC, 1 package rows | 20240110_d6fba129-ac6e-4d04-bd09-8470be4e7ecc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-090-01 | 42291009001 | 100 TABLET in 1 BOTTLE (42291-090-01) | 100 tablet | 2017-05-18 | 0000-00-00 | No | No | Current |